Año: 2010
Journal Impact Factor (JIF): 4.3570
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
OBSTETRICS & GYNECOLOGY | SCIE | 3/77 | Q1 | T1 | D1 |
REPRODUCTIVE BIOLOGY | SCIE | 2/26 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 2,230
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
OBSTETRICS & GYNECOLOGY | 2/115 | Q1 | T1 | D1 | 98,70 |
REPRODUCTIVE BIOLOGY | 2/31 | Q1 | T1 | D1 | 95,16 |
Año:
2011
CiteScore:
8,100
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
General Medicine | 283/3161 | Q1 | T1 | D1 |
Obstetrics and Gynecology | 2/155 | Q1 | T1 | D1 |
Rehabilitation | 2/101 | Q1 | T1 | D1 |
Reproductive Medicine | 2/52 | Q1 | T1 | D1 |
SJR año:
2010
Factor de Impacto:
2,263
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Obstetrics and Gynecology | 2/194 | Q1 | T1 | D1 |
Rehabilitation | 1/125 | Q1 | T1 | D1 |
Reproductive Medicine | 2/71 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Ferring Pharmaceuticals, Copenhagen, Denmark | - |
Merck Serono | - |
Organon | - |
Schering-Plough | - |
Serono | - |
# | Autor | Afiliación |
---|---|---|
1 | IVI Valencia (Spain) | |
2 | Fernández-Sánchez, Manuel | IVI Sevilla (Spain) |
3 | García-Velasco, Juan Antonio | IVI-Madrid (Spain) |
4 | Landeras, José | IVI-Murcia (Spain) |
5 | Ballesteros, Augustín | IVI Barcelona (Spain) |
6 | Muñoz, Elkin | IVI Vigo (Spain) |
7 | González, Sandra | IVI Bilbao (Spain) |
8 | Simón, Carlos | IVI Valencia (Spain) |
9 | Arce, Joan Carles | Ferring Pharmaceuticals AS (Switzerland) |
10 | Pellicer, Antonio | IVI Valencia (Spain) |